Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
03/1998
03/26/1998CA2265522A1 Retroviral vectors capable of transducing non-dividing cells
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830142A1 Viral agent associated with mystery swine disease
03/25/1998EP0830062A1 Controlling hemipteran insect pests with bacillus thuringiensis
03/25/1998EP0830057A1 Method of inactivation of viral and bacterial blood contaminants
03/25/1998EP0714306B1 Inactivated respiratory syncytial viral vaccines
03/25/1998CN1177006A Incasing cell series for prodn. of recombined adenovirus accompanying virus, and the application thereof
03/24/1998US5731190 Penton base protein and methods of using same
03/24/1998US5731188 Vaccine
03/24/1998US5731008 Electrically hydrolyzed salines as microbicides
03/24/1998CA1339774C Recombinant marek's disease virus, process for preparing the same and vaccine containing the same
03/19/1998WO1998011244A2 Aav4 vector and uses thereof
03/19/1998WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/19/1998WO1998011133A1 New picornaviruses, vaccines and diagnostic kits
03/19/1998CA2265460A1 Aav4 vector and uses thereof
03/19/1998CA2264966A1 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein
03/18/1998EP0828832A2 $g(D)P62, ITS VARIANTS, NUCLEIC ACID SEQUENCES ENCODING THEM, AND THEIR USES IN ANTI-CANCER GENE THERAPY
03/18/1998EP0828823A1 Herpes simplex type 1 protease mutants and vectors
03/18/1998EP0828756A2 Diagnosis of, and vaccination against, a positive stranded rna virus using an isolated, unprocessed polypeptide
03/18/1998EP0828519A1 Recombinant viral vector system
03/17/1998US5728569 Inoculation of embryonated eggs, propagation, harvesting
03/17/1998US5728386 Thermostable varicella zoster virus
03/17/1998US5728379 Tumor- or cell-specific herpes simplex virus replication
03/17/1998CA1339732C Synthesis and immunogenicity of rotavirus genes using baculovirus expression system
03/12/1998WO1998010100A1 Method and kit for the diagnosis of blackcurrant reversion disease
03/12/1998WO1998010088A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
03/12/1998WO1998010086A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998WO1998010085A2 Gene therapy for congestive heart failure
03/12/1998WO1998010084A1 Tetracycline transactivator having a nuclear localization signal joined thereto
03/12/1998WO1998010083A1 Herpesvirus saimiri as viral vector
03/12/1998WO1998010071A1 Angiogenic factor and use thereof in treating cardiovascular disease
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009646A1 A method for generating birnavirus from synthetic rna transcripts
03/12/1998WO1998009505A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998WO1997038087A3 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
03/12/1998CA2718347A1 Gene therapy for congestive heart failure
03/12/1998CA2264956A1 Herpesvirus saimiri as viral vector
03/12/1998CA2264499A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998CA2264489A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998CA2264482A1 An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0827547A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5725862 Vaccine for branhamelia catarrhalis
03/06/1998CA2209890A1 Apoptotic agents for tumor cells of the nervous system
03/05/1998WO1998008936A1 Recombinant canine herpesvirus
03/05/1998WO1998008934A1 Serum-free mammalian cell culture medium, and uses thereof
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/04/1998EP0826775A1 Vector system for conditional gene expression
03/04/1998EP0826060A2 Embedded expression of heterologous proteins
03/04/1998EP0826047A1 Recombinant baculovirus insecticides
03/04/1998EP0554389B1 Molecular clones of hiv-1 and uses thereof
03/04/1998EP0542949B1 Hepatitis a virus strain, method for the isolation of said virus strains and hepatitis a vaccines
03/04/1998EP0390799B1 Respiratory syncytial virus: vaccines
03/03/1998US5723440 Insecticides and pesticides
03/03/1998US5723287 Retroviral particle comprising fusion protein and nucleic acid; genetic engineering
03/03/1998US5723286 Peptide library and screening systems
02/1998
02/26/1998WO1998007877A1 A short-shafted adenoviral fiber and its use
02/26/1998WO1998001570A3 Mutated antibody-dependent infection enhancing domains of hiv
02/26/1998CA2263189A1 A short-shafted adenoviral fiber and its use
02/25/1998EP0824361A1 Stable virus packaging cell lines
02/25/1998CN1174509A Gene transfer-mediated angiogenesis therapy
02/24/1998US5721354 For treatment of infections, medical diagnosis
02/24/1998US5721352 Entomopoxvirus expression system
02/24/1998US5721351 Compositions and methods for the treatment and diagnosis of immune disorders
02/24/1998US5721120 Method of disrupting cultured cells using an impinging jet device
02/24/1998US5720957 Recombinant human cytomegalovirus vaccine
02/19/1998WO1998006828A1 Phage bonded to nuclear location signal
02/19/1998WO1998006827A2 Method for immortalizing cells
02/19/1998WO1998006824A1 Immortalized cell lines for virus growth
02/19/1998WO1998006744A1 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides
02/19/1998DE19633684A1 Verfahren zur Inaktivierung von lipidumhüllten Viren A method of inactivating lipid-enveloped viruses
02/19/1998CA2265888A1 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides
02/19/1998CA2262529A1 Phage bonded to nuclear location signal
02/17/1998US5719049 Process for purifying hepatitis A virus (HAV), virus thus purified and vaccine compositions containing it
02/11/1998EP0822980A1 Recombinant infectious laryngotracheitis virus and uses thereof
02/11/1998EP0822979A1 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same
02/11/1998CN1173203A Purified papillomavirus proteins
02/11/1998CN1173135A Use of bioassimilable boron compounds for the control of subviral pathogenic agents
02/10/1998US5717069 Insecticide
02/10/1998US5716832 Growing packaging cells having viral protein-coding sequences which produce target cell-specific retroviruses; gene therapy, antitumor agents
02/10/1998US5716826 Recombinant retroviruses
02/10/1998US5716620 Vaccines, diagnostic immunoassay
02/10/1998US5716613 Genetic engineering
02/05/1998WO1998004728A1 Recombinant pox virus for immunization against tumor-associated antigens
02/05/1998WO1998004727A1 Recombinant pox virus for immunization against tumor-associated antigens
02/05/1998WO1998004726A1 Hsv strain lacking functional icp27 and icp34.5 genes
02/05/1998WO1998004684A1 Recombinant swinepox virus
02/05/1998WO1998004286A2 Assembly-deficient herpesvirus vaccine
02/05/1998WO1998004285A1 Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression
02/05/1998WO1997032991A3 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
02/05/1998DE19727830A1 Selektives Adsorbens zur Bindung von Retroviren Selective adsorbent for binding retroviruses
02/05/1998CA2261990A1 Recombinant pox virus for immunization against tumor-associated antigens
02/05/1998CA2261071A1 Assembly-deficient herpesvirus vaccine
02/04/1998EP0821741A1 Glucose-inducible recombinant viral vector
02/04/1998EP0821739A1 An adenovirus helper-virus system
02/04/1998EP0821693A1 Novel human cytomegalovirus dna sequences
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 267